Sopharma issued the following announcement on Aug. 5
Sofia, Bulgaria, August 5, 2019 – Sopharma AD notifies that for July 2019 the Company recorded a decrease in sales of 11% compared to the same month of 2018, incl. 3% decrease in sales for the domestic market and 16% decrease in export sales.
In the first seven months of 2019 the revenues from sales of production decreased by 1% compared to the same period of 2018, incl. 10% decrease in domestic sales and 5% increase of export sales.
